 Helsinn and Immedica enter exclusive partnership for commercialisation of cancer supportive care products in core European markets LUGANO, Switzerland and STOCKHOLM, Sweden January 24, 2023 Helsinn Group Helsinn, a fully integrated global biopharma company with a track record of over forty years of commercial execution and a strong focus in oncology and rare... The post Helsinn and Immedica enter exclusive partnership for commercialisation of cancer supportive care products in core Europea... 